Max Healthcare Institute Q2 Results 2025 Highlights: Net Profit Surged by 74.34% & Revenue Up 25.07% YoY

Max Healthcare Institute Q2 Results FY26: During Q2 FY26, Max Healthcare Institute's profit increased 74.34% YoY, while revenue increased by 25.07% YoY. The company posted robust numbers, with Q2 PAT at ₹491.30 crores and revenue at ₹2,135.47 crores. Max Healthcare Institute showed its Q2 results on 14th November 2025.  

Max Healthcare Institute Q2 Results FY26: Extracts of FY25 & FY26

Particulars	Consolidated Figures		Standalone Figures
	30th Sep 2025	30 Sept 2024	30th Sept 2025	30th Sept 2024
Revenue from Operations	₹2,135.47	₹1,707.46	₹736.62	₹686.11
Profit Before Tax (PBT)	₹608.05	₹491.38	₹261.10	₹358.18
Profit After Tax (PAT)	₹491.30	₹281.81	₹160.42	₹231.30

Max Healthcare Institute Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Max Healthcare Institute clocked Q2 FY26 consolidated revenue of ₹2,135.47 crores vs ₹1,707.46 crores. 
• On the profit front, Max Healthcare Institute earned a consolidated PAT of ₹491.30 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹281.81 crore.
• According to the consolidated figures, Max Healthcare Institute's quarterly PAT increased by 74.34% YoY, while revenue increased by 25.07%.
• Max Healthcare Institute clocked Q2 FY26 standalone revenue of ₹736.62 crores vs ₹686.11 crores. 
• On the profit front,  Max Healthcare Institute earned a standalone PAT of ₹160.42 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹231.30 crore.
• According to the standalone figures,  Max Healthcare Institute's quarterly PAT decreased by 30.64% YoY, while revenue increased by 7.36%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

Max Healthcare Institute Share Price Performance 

On the opening bell on 25th November 2025,  Max Healthcare Institute shares opened at ₹1,171.40 per share. However, the initial gains have since eroded, and Max Healthcare Institute shares are currently trading at ₹1,162.40 per share, which is lower than the opening price.    

Considering the long-term performance, Max Healthcare Institute shares have yielded returns of approximately -1.00% over the past 6 months and 19.62% over the past 1 year. Over the maximum timeframe, Max Healthcare Institute shares delivered a 940.18% return to investors. 

What Analysts Expect Post Q2 Results?

Following Max Healthcare Institute's robust Q2 results for FY26, analysts expect its share price to rise. According to analysts, Max Healthcare Institute's share price could reach ₹1,248.40 per share in the coming year and, in a downturn, could hit ₹1,143.90 per share. However, one must ignore stock market volatility and invest in  Max Healthcare Institute shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here